Table 3.

Humoral immunity indices in patients with gastric cancer over the course of treatment

Patient group	Therapy stage	IL-2	TNFα	IFNγ
I-control	2.45±0.08*	0.85±0.15*	9.46±0.6*	5.65±0.03*
chemotherapy + surgery	2.28±0.09	0.80±0.12	8.68±0.4	6.52±0.05**
II-experimental	2.38±0.09*	1.04±0.03*	10.51±0.15*	5.45±0.07*
chemoimmunotherapy + surgery	2.46±0.10	1.05±0.04	10.74±0.16	4.69±0.06**
In health	3.77±0.06	1.21±0.06	12.10±0.16	3.37±0.05

^*difference between the index before treatment and in health is significant, p<0.05

^**difference between the index before and after treatment is significant, p<0.05

numerator-index before treatment, denominator-index after treatment